Oakes D - Search Results

1

Predictive Value of Verbatim Parkinson's Disease Patient-Reported Symptoms of Postural Instability and Falling.

Javidnia M, Arbatti L, Hosamath A, Eberly SW, Oakes D, Shoulson I. Javidnia M, et al. Among authors: oakes d. J Parkinsons Dis. 2021;11(4):1957-1964. doi: 10.3233/JPD-212636. J Parkinsons Dis. 2021. PMID: 34250951 Free PMC article.

2

Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson's Disease Trials.

Shoulson I, Arbatti L, Hosamath A, Eberly SW, Oakes D. Shoulson I, et al. Among authors: oakes d. J Parkinsons Dis. 2022;12(6):1969-1978. doi: 10.3233/JPD-223274. J Parkinsons Dis. 2022. PMID: 35694935 Free PMC article.

3

Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trial.

Jennings D, Eberly S, Oakes D, Seibyl J, Marek K, Shoulson I; Parkinson Study Group PRECEPT Investigators. Jennings D, et al. Among authors: oakes d. J Parkinsons Dis. 2014;4(4):629-38. doi: 10.3233/JPD-140383. J Parkinsons Dis. 2014. PMID: 25062961 Clinical Trial.

4

Informativeness of Early Huntington Disease Signs about Gene Status.

Oster E, Eberly SW, Dorsey ER, Kayson-Rubin E, Oakes D, Shoulson I. Oster E, et al. Among authors: oakes d. J Huntingtons Dis. 2015;4(3):271-7. doi: 10.3233/JHD-150156. J Huntingtons Dis. 2015. PMID: 26444024

5

The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation.

Kayson E, Eberly S, Anderson KE, Marder K, Shoulson I, Oakes D, Young AB, Biglan K, Hersch S; Huntington Study Group PHAROS Investigators. Kayson E, et al. Among authors: oakes d. J Huntingtons Dis. 2019;8(4):435-441. doi: 10.3233/JHD-190365. J Huntingtons Dis. 2019. PMID: 31381523

6

Isradipine plasma pharmacokinetics and exposure-response in early Parkinson's disease.

Venuto CS, Yang L, Javidnia M, Oakes D, James Surmeier D, Simuni T. Venuto CS, et al. Among authors: oakes d. Ann Clin Transl Neurol. 2021 Mar;8(3):603-612. doi: 10.1002/acn3.51300. Epub 2021 Jan 18. Ann Clin Transl Neurol. 2021. PMID: 33460320 Free PMC article. Clinical Trial.

7

Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease.

Kurlan R, Ravina B, Eberly S, Lang AE, Tanner CM, Marek K, Marder K, Beck J, Elliott R, Oakes D, Shoulson I; PSG PostCEPT (LABS‐PD) Investigators. Kurlan R, et al. Among authors: oakes d. Mov Disord Clin Pract. 2015 Dec 14;3(1):53-58. doi: 10.1002/mdc3.12273. eCollection 2016 Jan-Feb. Mov Disord Clin Pract. 2015. PMID: 30363507 Free PMC article.

8

Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease.

Tanner C, Marder K, Eberly S, Biglan K, Oakes D, Shoulson I; Huntington Study Group Prospective Huntington At-Risk Observational Study Investigators. Tanner C, et al. Among authors: oakes d. Mov Disord. 2018 Mar;33(3):472-478. doi: 10.1002/mds.27239. Epub 2018 Jan 3. Mov Disord. 2018. PMID: 29297592 Free PMC article.

9

Quaid KA, Eberly SW, Kayson-Rubin E, Oakes D, Shoulson I; Huntington Study Group PHAROS Investigators and Coordinators. Quaid KA, et al. Among authors: oakes d. Clin Genet. 2017 Jun;91(6):824-831. doi: 10.1111/cge.12893. Epub 2016 Nov 24. Clin Genet. 2017. PMID: 27740685 Free PMC article.

10

Longitudinal follow-up of SWEDD subjects in the PRECEPT Study.

Marek K, Seibyl J, Eberly S, Oakes D, Shoulson I, Lang AE, Hyson C, Jennings D; Parkinson Study Group PRECEPT Investigators. Marek K, et al. Among authors: oakes d. Neurology. 2014 May 20;82(20):1791-7. doi: 10.1212/WNL.0000000000000424. Epub 2014 Apr 23. Neurology. 2014. PMID: 24759846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page